XKH001

TypeInjection StageNo phase reached Latest updateJul 8, 2025Phase 2 study posted

What stands out

Injection every 4 weeks in trials

Derived from NCT07054736 ·

4 US eczema labels

(Dupixent, Ebglyss, Nemluvio, Adbry)

· This is a summary of public records for informational purposes only. It is not medical advice.

History

Earliest recorded event: Jul 8, 2025. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

Jul 8, 2025Phase 2 trial postedEvaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis ClinicalTrials.gov NCT07054736

Sources

Trials

NCT07054736